Epijoint

Epijoint is a new nutraceutical joint health product for relieving the symptoms of osteoarthritis such as pain, stiffness and inflammation whilst improving joint function. Epijoint contains Epiitalis, an exclusive and clinically trialled ingredient that is patented for its anti-inflammatory effects and joint cartilage health benefits. Epijoint is Australian owned and created by Interpath Global – an R&D company established in 1998, which specialises in osteoarthritis clinical research and the development of joint health product lines in both human and animal markets internationally. Interpaths key animal range is called 4CYTE (for dogs, horses and cats) and is the top selling natural veterinary joint health product range in Australasia. It is stocked in over 90% of Australian veterinary clinics.